BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 30297392)

  • 1. p38α MAPK signaling drives pharmacologically reversible brain and gastrointestinal phenotypes in the SERT Ala56 mouse.
    Robson MJ; Quinlan MA; Margolis KG; Gajewski-Kurdziel PA; Veenstra-VanderWeele J; Gershon MD; Watterson DM; Blakely RD
    Proc Natl Acad Sci U S A; 2018 Oct; 115(43):E10245-E10254. PubMed ID: 30297392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rare Opportunities for Insights Into Serotonergic Contributions to Brain and Bowel Disorders: Studies of the SERT Ala56 Mouse.
    Stilley SE; Blakely RD
    Front Cell Neurosci; 2021; 15():677563. PubMed ID: 34149362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin transporter variant drives preventable gastrointestinal abnormalities in development and function.
    Margolis KG; Li Z; Stevanovic K; Saurman V; Israelyan N; Anderson GM; Snyder I; Veenstra-VanderWeele J; Blakely RD; Gershon MD
    J Clin Invest; 2016 Jun; 126(6):2221-35. PubMed ID: 27111230
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Quinlan MA; Robson MJ; Ye R; Rose KL; Schey KL; Blakely RD
    Front Mol Neurosci; 2020; 13():89. PubMed ID: 32581705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A requirement of serotonergic p38α mitogen-activated protein kinase for peripheral immune system activation of CNS serotonin uptake and serotonin-linked behaviors.
    Baganz NL; Lindler KM; Zhu CB; Smith JT; Robson MJ; Iwamoto H; Deneris ES; Hewlett WA; Blakely RD
    Transl Psychiatry; 2015 Nov; 5(11):e671. PubMed ID: 26529424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Serotonin Transporter Coding Variation Establishes Conformational Bias with Functional Consequences.
    Quinlan MA; Krout D; Katamish RM; Robson MJ; Nettesheim C; Gresch PJ; Mash DC; Henry LK; Blakely RD
    ACS Chem Neurosci; 2019 Jul; 10(7):3249-3260. PubMed ID: 30668912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior.
    Veenstra-VanderWeele J; Muller CL; Iwamoto H; Sauer JE; Owens WA; Shah CR; Cohen J; Mannangatti P; Jessen T; Thompson BJ; Ye R; Kerr TM; Carneiro AM; Crawley JN; Sanders-Bush E; McMahon DG; Ramamoorthy S; Daws LC; Sutcliffe JS; Blakely RD
    Proc Natl Acad Sci U S A; 2012 Apr; 109(14):5469-74. PubMed ID: 22431635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin as a link between the gut-brain-microbiome axis in autism spectrum disorders.
    Israelyan N; Margolis KG
    Pharmacol Res; 2018 Jun; 132():1-6. PubMed ID: 29614380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic background modulates phenotypes of serotonin transporter Ala56 knock-in mice.
    Kerr TM; Muller CL; Miah M; Jetter CS; Pfeiffer R; Shah C; Baganz N; Anderson GM; Crawley JN; Sutcliffe JS; Blakely RD; Veenstra-Vanderweele J
    Mol Autism; 2013 Oct; 4(1):35. PubMed ID: 24083388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin 5-HT
    O'Reilly KC; Connor M; Pierson J; Shuffrey LC; Blakely RD; Ahmari SE; Veenstra-VanderWeele J
    Psychopharmacology (Berl); 2021 Apr; 238(4):1111-1120. PubMed ID: 33511450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Maternal Serotonin Transporter Genotype on Placental Serotonin, Fetal Forebrain Serotonin, and Neurodevelopment.
    Muller CL; Anacker AM; Rogers TD; Goeden N; Keller EH; Forsberg CG; Kerr TM; Wender C; Anderson GM; Stanwood GD; Blakely RD; Bonnin A; Veenstra-VanderWeele J
    Neuropsychopharmacology; 2017 Jan; 42(2):427-436. PubMed ID: 27550733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flowers for Algernon: steroid dysgenesis, epigenetics and brain disorders.
    Sanders BK
    Pharmacol Rep; 2012; 64(6):1285-90. PubMed ID: 23406739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A social encounter drives gene expression changes linked to neuronal function, brain development, and related disorders in mice expressing the serotonin transporter Ala56 variant.
    O'Reilly KC; Anacker AMJ; Rogers TD; Forsberg CG; Wang J; Zhang B; Blakely RD; Veenstra-VanderWeele J
    Neurosci Lett; 2020 Jun; 730():135027. PubMed ID: 32437898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p38 MAPK activation elevates serotonin transport activity via a trafficking-independent, protein phosphatase 2A-dependent process.
    Zhu CB; Carneiro AM; Dostmann WR; Hewlett WA; Blakely RD
    J Biol Chem; 2005 Apr; 280(16):15649-58. PubMed ID: 15728187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The serotonin system in autism spectrum disorder: From biomarker to animal models.
    Muller CL; Anacker AMJ; Veenstra-VanderWeele J
    Neuroscience; 2016 May; 321():24-41. PubMed ID: 26577932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective p38α MAPK deletion in serotonergic neurons produces stress resilience in models of depression and addiction.
    Bruchas MR; Schindler AG; Shankar H; Messinger DI; Miyatake M; Land BB; Lemos JC; Hagan CE; Neumaier JF; Quintana A; Palmiter RD; Chavkin C
    Neuron; 2011 Aug; 71(3):498-511. PubMed ID: 21835346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in social brain function in autism spectrum disorder are linked to the serotonin transporter: A randomised placebo-controlled single-dose crossover trial.
    Wong NM; Dipasquale O; Turkheimer F; Findon JL; Wichers RH; Dimitrov M; Murphy CM; Stoencheva V; Robertson DM; Murphy DG; Daly E; McAlonan GM
    J Psychopharmacol; 2022 Jun; 36(6):723-731. PubMed ID: 35491679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain hyperserotonemia causes autism-relevant social deficits in mice.
    Tanaka M; Sato A; Kasai S; Hagino Y; Kotajima-Murakami H; Kashii H; Takamatsu Y; Nishito Y; Inagaki M; Mizuguchi M; Hall FS; Uhl GR; Murphy D; Sora I; Ikeda K
    Mol Autism; 2018; 9():60. PubMed ID: 30498565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for p38 mitogen-activated protein kinase in the regulation of the serotonin transporter: evidence for distinct cellular mechanisms involved in transporter surface expression.
    Samuvel DJ; Jayanthi LD; Bhat NR; Ramamoorthy S
    J Neurosci; 2005 Jan; 25(1):29-41. PubMed ID: 15634764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Gain-of-Function Integrin β3 Pro33 Variant Alters the Serotonin System in the Mouse Brain.
    Dohn MR; Kooker CG; Bastarache L; Jessen T; Rinaldi C; Varney S; Mazalouskas MD; Pan H; Oliver KH; Velez Edwards DR; Sutcliffe JS; Denny JC; Carneiro AMD
    J Neurosci; 2017 Nov; 37(46):11271-11284. PubMed ID: 29038237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.